BCSCDB: Biomarkers of Cancer Stem Cells Database
Number of marker genes starting with is 193
| GENE | HGNC_ID | CANCER_TYPE | HISTOLOGICAL_TYPE | CSC_ENRICHMENT | METHOD | CONFIDENCE_SCORING | GLOBAL_SCORING | PUBMED_ID |
|---|---|---|---|---|---|---|---|---|
| CD44 | 1681 | Colon Cancer | NA | NA | qRT-PCR and Western Blotting followed by SFA | 0.64 | 1 | 34271345 |
| CD44 | 1681 | Colon Cancer | NA | NA | IHC staining followed by qRT-PCR | 0.64 | 1 | 33819194 |
| CD44 | 1681 | Colon Cancer | NA | NA | IHC staining followed by RT-PCR | 0.64 | 1 | 19010307 |
| CD44 | 1681 | Colon Cancer | NA | NA | qRT-PCR followed by IHC staining | 0.64 | 1 | 25625240 |
| CD44 | 1681 | Colon Cancer | NA | NA | RT-PCR and IHC staining | 0.64 | 1 | 25625240 |
| CD44 | 1681 | Colon Cancer | NA | NA | SFA followed by FACs and IF staining | 0.64 | 1 | 23642368 |
| CD44 | 1681 | Colon Cancer | NA | NA | Tumorigenicity assay and SFA followed by IHC staining and FACs | 0.64 | 1 | 19808966 |
| CD44 | 1681 | Colon Cancer | NA | Blebbistatin | SFA followed by Western Blotting | 0.64 | 1 | 23002207 |
| CD44 | 1681 | Colon Cancer | NA | NA | IHC staining | 0.64 | 1 | 35249490 |
| CD44 | 1681 | Colon Cancer | NA | NA | IHC staining | 0.64 | 1 | 34609414 |
| CD44 | 1681 | Colon Cancer | NA | NA | IHC staining | 0.64 | 1 | 22740326 |
| CD44 | 1681 | Colon Cancer | NA | NA | IHC staining | 0.64 | 1 | 24696849 |
| CD44 | 1681 | Colon Cancer | NA | NA | IHC staining | 0.64 | 1 | 25109336 |
| CD44 | 1681 | Colon Cancer | NA | NA | IHC staining | 0.64 | 1 | 29102042 |
| CD44 | 1681 | Colon Cancer | NA | NA | IHC staining | 0.64 | 1 | 31000786 |
| CD44 | 1681 | Colon Cancer | NA | NA | IHC staining | 0.64 | 1 | 31578584 |
| CD44 | 1681 | Colon Cancer | NA | NA | SFA and IF staining | 0.64 | 1 | 24607406 |
| CD44 | 1681 | Colon Cancer | NA | NA | qRT-PCR | 0.64 | 1 | 35392530 |
| CD44 | 1681 | Colon Cancer | NA | NA | qRT-PCR | 0.64 | 1 | 24492635 |
| CD44 | 1681 | Colon Cancer | NA | NA | FACs | 0.64 | 1 | 27354640 |
| CD44 | 1681 | Colon Cancer | Adenocarcinoma | NA | FACs | 0.64 | 1 | 29580161 |
| CD44 | 1681 | Colon Cancer | NA | NA | FACs | 0.64 | 1 | 31973205 |
| CD44 | 1681 | Colon Cancer | NA | NA | FACs followed by CFA | 0.64 | 1 | 18757407 |
| CD44 | 1681 | Colon Cancer | NA | NA | FACs followed by SFA | 0.64 | 1 | 26745821 |
| CD44 | 1681 | Colon Cancer | NA | NA | FACs followed by SFA and Tumorigenicity assay | 0.64 | 1 | 30790680 |
| CD44 | 1681 | Colon Cancer | NA | NA | SFA followed by FACs | 0.64 | 1 | 18765800 |
| CD44 | 1681 | Colon Cancer | NA | NA | SFA followed by FACs | 0.64 | 1 | 26383537 |
| CD44 | 1681 | Colon Cancer | NA | NA | SFA followed by FACs | 0.64 | 1 | 23643941 |
| CD44 | 1681 | Colon Cancer | NA | ROCK inhibitor | SFA followed by FACs and Tumorigenicity assay | 0.64 | 1 | 23002207 |
| CD44 | 1681 | Colon Cancer | NA | Y-27632 | SFA followed by FACs and Tumorigenicity assay | 0.64 | 1 | 23002207 |
| CD44 | 1681 | Colon Cancer | NA | NA | SFA followed by FACs and Tumorigenicity assay | 0.64 | 1 | 29110645 |
| LGR5 | 4504 | Colon Cancer | NA | NA | RT-PCR followed by Western Blotting | 0.64 | 0.0753 | 28249897 |
| LGR5 | 4504 | Colon Cancer | NA | NA | SFA followed by FACs and IHC staining | 0.64 | 0.0753 | 18765800 |
| LGR5 | 4504 | Colon Cancer | NA | NA | IHC staining | 0.64 | 0.0753 | 29102042 |
| LGR5 | 4504 | Colon Cancer | NA | NA | IHC staining | 0.64 | 0.0753 | 29328371 |
| LGR5 | 4504 | Colon Cancer | NA | NA | IHC staining | 0.64 | 0.0753 | 31000786 |
| LGR5 | 4504 | Colon Cancer | NA | NA | IHC staining | 0.64 | 0.0753 | 31186779 |
| LGR5 | 4504 | Colon Cancer | NA | NA | SFA and IF staining | 0.64 | 0.0753 | 26745821 |
| LGR5 | 4504 | Colon Cancer | NA | NA | RT-PCR | 0.64 | 0.0753 | 21125339 |
| LGR5 | 4504 | Colon Cancer | NA | NA | RT-PCR | 0.64 | 0.0753 | 31057717 |
| LGR5 | 4504 | Colon Cancer | NA | NA | SFA followed by FACs | 0.64 | 0.0753 | 25483065 |
| LGR5 | 4504 | Colon Cancer | NA | NA | SFA followed by FACs | 0.64 | 0.0753 | 27197180 |
| LGR5 | 4504 | Colon Cancer | NA | NA | SFA followed by FACs | 0.64 | 0.0753 | 23643941 |
| LGR5 | 4504 | Colon Cancer | NA | NA | IF staining | 0.64 | 0.0753 | 35008827 |
| LGR5 | 4504 | Colon Cancer | NA | NA | IHC staining | 0.64 | 0.0753 | 34657081 |
| NANOG | 20857 | Colon Cancer | NA | NA | RT-PCR followed by Western Blotting | 0.64 | 0.5461 | 28249897 |
| NANOG | 20857 | Colon Cancer | NA | NA | IHC staining followed by qRT-PCR | 0.64 | 0.5461 | 31491003 |
| NANOG | 20857 | Colon Cancer | NA | 5-Fluorouracil | SFA followed by Western Blotting | 0.64 | 0.5461 | 30091203 |
| NANOG | 20857 | Colon Cancer | NA | Oxaliplatin | SFA followed by Western Blotting | 0.64 | 0.5461 | 30091203 |
| NANOG | 20857 | Colon Cancer | NA | NA | qRT-PCR | 0.64 | 0.5461 | 24492635 |
| NANOG | 20857 | Colon Cancer | NA | NA | SFA followed by qRT-PCR | 0.64 | 0.5461 | 23643941 |
| NANOG | 20857 | Colon Cancer | NA | 5-Fluorouracil | SFA followed by FACs | 0.64 | 0.5461 | 30091203 |
| NANOG | 20857 | Colon Cancer | NA | Oxaliplatin | SFA followed by FACs | 0.64 | 0.5461 | 30091203 |
| NANOG | 20857 | Colon Cancer | NA | NA | qRT-PCR and Western Blotting followed by SFA | 0.64 | 0.5461 | 34271345 |
| NANOG | 20857 | Colon Cancer | NA | NA | SFA followed by Western Blotting | 0.64 | 0.5461 | 33500430 |
| NOTCH3 | 7883 | Colon Cancer | NA | NA | RT-PCR followed by Western Blotting | 0.64 | 0.0085 | 28249897 |
| POU5F1 | 9221 | Colon Cancer | NA | NA | RT-PCR followed by Western Blotting | 0.64 | 0.6448 | 28249897 |
| POU5F1 | 9221 | Colon Cancer | NA | NA | SFA followed by Western Blotting | 0.64 | 0.6448 | 29110645 |
| POU5F1 | 9221 | Colon Cancer | NA | 5-Fluorouracil | SFA followed by Western Blotting | 0.64 | 0.6448 | 30091203 |
| POU5F1 | 9221 | Colon Cancer | NA | Oxaliplatin | SFA followed by Western Blotting | 0.64 | 0.6448 | 30091203 |
| POU5F1 | 9221 | Colon Cancer | NA | NA | IHC staining | 0.64 | 0.6448 | 30177970 |
| POU5F1 | 9221 | Colon Cancer | NA | NA | IHC staining | 0.64 | 0.6448 | 31491003 |
| POU5F1 | 9221 | Colon Cancer | NA | NA | SFA and IF staining | 0.64 | 0.6448 | 26745821 |
| POU5F1 | 9221 | Colon Cancer | NA | NA | RT-PCR | 0.64 | 0.6448 | 23545848 |
| POU5F1 | 9221 | Colon Cancer | NA | NA | SFA followed by qRT-PCR | 0.64 | 0.6448 | 23643941 |
| POU5F1 | 9221 | Colon Cancer | NA | 5-Fluorouracil | SFA followed by FACs | 0.64 | 0.6448 | 30091203 |
| POU5F1 | 9221 | Colon Cancer | NA | Oxaliplatin | SFA followed by FACs | 0.64 | 0.6448 | 30091203 |
| POU5F1 | 9221 | Colon Cancer | NA | NA | qRT-PCR and Western Blotting followed by SFA | 0.64 | 0.6448 | 34271345 |
| POU5F1 | 9221 | Colon Cancer | NA | NA | SFA followed by Western Blotting | 0.64 | 0.6448 | 33500430 |
| SOX2 | 11195 | Colon Cancer | NA | NA | qRT-PCR and Western Blotting followed by SFA | 0.64 | 0.5695 | 34271345 |
| SOX2 | 11195 | Colon Cancer | NA | NA | SFA followed by Western Blotting | 0.64 | 0.5695 | 33500430 |
| SOX2 | 11195 | Colon Cancer | NA | NA | SFA followed by Western Blotting | 0.64 | 0.5695 | 29110645 |
| SOX2 | 11195 | Colon Cancer | NA | 5-Fluorouracil | SFA followed by Western Blotting | 0.64 | 0.5695 | 30091203 |
| SOX2 | 11195 | Colon Cancer | NA | Oxaliplatin | SFA followed by Western Blotting | 0.64 | 0.5695 | 30091203 |
| SOX2 | 11195 | Colon Cancer | NA | NA | IHC staining | 0.64 | 0.5695 | 29102042 |
| SOX2 | 11195 | Colon Cancer | NA | NA | IHC staining | 0.64 | 0.5695 | 31186779 |
| SOX2 | 11195 | Colon Cancer | NA | NA | SFA and IF staining | 0.64 | 0.5695 | 26745821 |
| SOX2 | 11195 | Colon Cancer | NA | NA | RT-PCR | 0.64 | 0.5695 | 23545848 |
| SOX2 | 11195 | Colon Cancer | NA | 5-Fluorouracil | SFA followed by FACs | 0.64 | 0.5695 | 30091203 |
| SOX2 | 11195 | Colon Cancer | NA | Oxaliplatin | SFA followed by FACs | 0.64 | 0.5695 | 30091203 |
| ALCAM | 400 | Colon Cancer | NA | NA | IHC staining followed by RT-PCR | 0.6 | 0.0583 | 19010307 |
| ALCAM | 400 | Colon Cancer | NA | NA | IHC staining | 0.6 | 0.0583 | 22670157 |
| ALCAM | 400 | Colon Cancer | NA | NA | FACs followed by CFA | 0.6 | 0.0583 | 18757407 |
| ALCAM | 400 | Colon Cancer | NA | NA | SFA followed by FACs | 0.6 | 0.0583 | 18765800 |
| ALCAM | 400 | Colon Cancer | NA | NA | SFA followed by FACs and Tumorigenicity assay | 0.6 | 0.0583 | 29110645 |
| EPCAM | 11529 | Colon Cancer | NA | NA | IHC staining followed by RT-PCR | 0.6 | 0.211 | 19010307 |
| EPCAM | 11529 | Colon Cancer | NA | NA | Tumorigenicity assay and SFA followed by IHC staining and FACs | 0.6 | 0.211 | 19808966 |
| EPCAM | 11529 | Colon Cancer | NA | NA | IHC staining | 0.6 | 0.211 | 22670157 |
| EPCAM | 11529 | Colon Cancer | NA | NA | IHC staining | 0.6 | 0.211 | 31491003 |
| EPCAM | 11529 | Colon Cancer | NA | NA | FACs | 0.6 | 0.211 | 27354640 |
| EPCAM | 11529 | Colon Cancer | Adenocarcinoma | NA | FACs | 0.6 | 0.211 | 29580161 |
| EPCAM | 11529 | Colon Cancer | NA | NA | FACs | 0.6 | 0.211 | 31057717 |
| EPCAM | 11529 | Colon Cancer | NA | NA | FACs followed by CFA | 0.6 | 0.211 | 18757407 |
| EPCAM | 11529 | Colon Cancer | NA | NA | SFA and FACs | 0.6 | 0.211 | 24944672 |
| EPCAM | 11529 | Colon Cancer | NA | NA | SFA followed by FACs | 0.6 | 0.211 | 20332776 |
| EPCAM | 11529 | Colon Cancer | NA | NA | SFA followed by FACs and Tumorigenicity assay | 0.6 | 0.211 | 19454726 |
| EPCAM | 11529 | Colon Cancer | NA | NA | IF staining | 0.6 | 0.211 | 35008827 |
| KLF4 | 6348 | Colon Cancer | NA | NA | IHC staining followed by qRT-PCR | 0.6 | 0.0891 | 31491003 |
| MYC | 7553 | Colon Cancer | NA | NA | IHC staining followed by qRT-PCR | 0.6 | 0.1304 | 31491003 |
| MYC | 7553 | Colon Cancer | NA | NA | RT-PCR | 0.6 | 0.1304 | 21125339 |
| PRDX2 | 9353 | Colon Cancer | NA | NA | IHC staining followed by qRT-PCR | 0.6 | 0.0074 | 33819194 |
| PROM1 | 9454 | Colon Cancer | NA | NA | qRT-PCR followed by IHC staining | 0.6 | 0.7582 | 25625240 |
| PROM1 | 9454 | Colon Cancer | NA | NA | RT-PCR and IHC staining | 0.6 | 0.7582 | 25625240 |
| PROM1 | 9454 | Colon Cancer | NA | NA | SFA followed by FACs and IF staining | 0.6 | 0.7582 | 27077950 |
| PROM1 | 9454 | Colon Cancer | NA | NA | SFA and Western Blotting | 0.6 | 0.7582 | 24833610 |
| PROM1 | 9454 | Colon Cancer | NA | NA | Western Blotting | 0.6 | 0.7582 | 24833610 |
| PROM1 | 9454 | Colon Cancer | NA | NA | IHC staining | 0.6 | 0.7582 | 19621338 |
| PROM1 | 9454 | Colon Cancer | NA | NA | IHC staining | 0.6 | 0.7582 | 22740326 |
| PROM1 | 9454 | Colon Cancer | NA | NA | IHC staining | 0.6 | 0.7582 | 22878609 |
| PROM1 | 9454 | Colon Cancer | NA | NA | IHC staining | 0.6 | 0.7582 | 22964035 |
| PROM1 | 9454 | Colon Cancer | NA | NA | IHC staining | 0.6 | 0.7582 | 29102042 |
| PROM1 | 9454 | Colon Cancer | NA | NA | IHC staining | 0.6 | 0.7582 | 29328371 |
| PROM1 | 9454 | Colon Cancer | NA | NA | IHC staining | 0.6 | 0.7582 | 31000786 |
| PROM1 | 9454 | Colon Cancer | NA | NA | SFA and IF staining | 0.6 | 0.7582 | 24607406 |
| PROM1 | 9454 | Colon Cancer | NA | NA | SFA followed by IHC staining | 0.6 | 0.7582 | 18371377 |
| PROM1 | 9454 | Colon Cancer | NA | NA | qRT-PCR | 0.6 | 0.7582 | 24492635 |
| PROM1 | 9454 | Colon Cancer | NA | NA | RT-PCR | 0.6 | 0.7582 | 23545848 |
| PROM1 | 9454 | Colon Cancer | NA | NA | FACs | 0.6 | 0.7582 | 31057717 |
| PROM1 | 9454 | Colon Cancer | NA | NA | FACs | 0.6 | 0.7582 | 31973205 |
| PROM1 | 9454 | Colon Cancer | NA | NA | FACs followed by CFA and Tumorigenicity assay | 0.6 | 0.7582 | 18757407 |
| PROM1 | 9454 | Colon Cancer | NA | NA | FACs followed by SFA | 0.6 | 0.7582 | 26745821 |
| PROM1 | 9454 | Colon Cancer | NA | NA | MACs | 0.6 | 0.7582 | 22753241 |
| PROM1 | 9454 | Colon Cancer | NA | NA | MACs followed by CFA and Tumorigenicity assay | 0.6 | 0.7582 | 20530554 |
| PROM1 | 9454 | Colon Cancer | NA | NA | MACs followed by Tumorigenicity assay and SFA | 0.6 | 0.7582 | 18371377 |
| PROM1 | 9454 | Colon Cancer | NA | NA | SFA and FACs | 0.6 | 0.7582 | 24944672 |
| PROM1 | 9454 | Colon Cancer | NA | NA | SFA followed by FACs | 0.6 | 0.7582 | 18765800 |
| PROM1 | 9454 | Colon Cancer | NA | NA | SFA followed by FACs | 0.6 | 0.7582 | 20332776 |
| PROM1 | 9454 | Colon Cancer | NA | NA | SFA followed by FACs | 0.6 | 0.7582 | 23642368 |
| PROM1 | 9454 | Colon Cancer | NA | NA | SFA followed by FACs | 0.6 | 0.7582 | 25483065 |
| PROM1 | 9454 | Colon Cancer | NA | NA | SFA followed by FACs | 0.6 | 0.7582 | 26383537 |
| PROM1 | 9454 | Colon Cancer | NA | NA | SFA followed by FACs | 0.6 | 0.7582 | 23643941 |
| PROM1 | 9454 | Colon Cancer | NA | NA | SFA followed by FACs and Tumorigenicity assay | 0.6 | 0.7582 | 19454726 |
| PROM1 | 9454 | Colon Cancer | NA | ROCK inhibitor | SFA followed by FACs and Tumorigenicity assay | 0.6 | 0.7582 | 23002207 |
| PROM1 | 9454 | Colon Cancer | NA | Y-27632 | SFA followed by FACs and Tumorigenicity assay | 0.6 | 0.7582 | 23002207 |
| PROM1 | 9454 | Colon Cancer | NA | NA | SFA followed by FACs and Tumorigenicity assay | 0.6 | 0.7582 | 29110645 |
| PROM1 | 9454 | Colon Cancer | NA | NA | IHC staining followed by qRT-PCR | 0.6 | 0.7582 | 33819194 |
| PROM1 | 9454 | Colon Cancer | NA | NA | IHC staining | 0.6 | 0.7582 | 34609414 |
| PROM1 | 9454 | Colon Cancer | NA | NA | qRT-PCR | 0.6 | 0.7582 | 35392530 |
| ALDH1A1 | 402 | Colon Cancer | NA | NA | SFA followed by ALDEFLUOR assay and IF staining | 0.52 | 0.684 | 23642368 |
| ALDH1A1 | 402 | Colon Cancer | NA | NA | SFA followed by FACs and IF staining | 0.52 | 0.684 | 27077950 |
| ALDH1A1 | 402 | Colon Cancer | NA | Oxaliplatin | SFA followed by Western Blotting | 0.52 | 0.684 | 30091203 |
| ALDH1A1 | 402 | Colon Cancer | NA | Oxaliplatin | SFA followed by Western Blotting | 0.52 | 0.684 | 30091203 |
| ALDH1A1 | 402 | Colon Cancer | NA | NA | IHC staining | 0.52 | 0.684 | 34609414 |
| ALDH1A1 | 402 | Colon Cancer | NA | NA | IHC staining | 0.52 | 0.684 | 22670157 |
| ALDH1A1 | 402 | Colon Cancer | NA | NA | IHC staining | 0.52 | 0.684 | 29102042 |
| ALDH1A1 | 402 | Colon Cancer | NA | NA | IHC staining | 0.52 | 0.684 | 29328371 |
| ALDH1A1 | 402 | Colon Cancer | NA | NA | IHC staining | 0.52 | 0.684 | 31000786 |
| ALDH1A1 | 402 | Colon Cancer | NA | NA | IHC staining | 0.52 | 0.684 | 31186779 |
| ALDH1A1 | 402 | Colon Cancer | NA | NA | IHC staining | 0.52 | 0.684 | 31516883 |
| ALDH1A1 | 402 | Colon Cancer | NA | NA | IHC staining followed by Tumorigenicity assay | 0.52 | 0.684 | 22902411 |
| ALDH1A1 | 402 | Colon Cancer | NA | NA | SFA and IHC staining | 0.52 | 0.684 | 24953984 |
| ALDH1A1 | 402 | Colon Cancer | NA | NA | Tumorigenicity assay followed by IHC staining and SFA | 0.52 | 0.684 | 19808966 |
| ALDH1A1 | 402 | Colon Cancer | NA | NA | qRT-PCR | 0.52 | 0.684 | 35392530 |
| ALDH1A1 | 402 | Colon Cancer | NA | NA | qRT-PCR | 0.52 | 0.684 | 24492635 |
| ALDH1A1 | 402 | Colon Cancer | NA | NA | ALDEFLUOR assay | 0.52 | 0.684 | 22902411 |
| ALDH1A1 | 402 | Colon Cancer | NA | NA | ALDEFLUOR assay | 0.52 | 0.684 | 27448961 |
| ALDH1A1 | 402 | Colon Cancer | NA | NA | ALDEFLUOR assay followed by SFA | 0.52 | 0.684 | 30738331 |
| ALDH1A1 | 402 | Colon Cancer | NA | NA | ALDEFLUOR assay followed byTumorigenicity assay | 0.52 | 0.684 | 28881576 |
| ALDH1A1 | 402 | Colon Cancer | NA | NA | FACs | 0.52 | 0.684 | 22871210 |
| ALDH1A1 | 402 | Colon Cancer | NA | NA | SFA followed by ALDEFLUOR assay | 0.52 | 0.684 | 27197176 |
| ALDH1A1 | 402 | Colon Cancer | NA | 5-Fluorouracil | SFA followed by FACs | 0.52 | 0.684 | 30091203 |
| ALDH1A1 | 402 | Colon Cancer | NA | Oxaliplatin | SFA followed by FACs | 0.52 | 0.684 | 30091203 |
| ALDH1A1 | 402 | Colon Cancer | NA | NA | SFA followed by FACs | 0.52 | 0.684 | 23643941 |
| COPE | 2234 | Colon Cancer | NA | NA | FACs for CSC marker followed by Transcriptomics and qPCR | 0.4 | 0.0021 | 20530554 |
| ABCG2 | 74 | Colon Cancer | NA | NA | SFA followed by Western Blotting | 0.36 | 0.1739 | 29110645 |
| ABCG2 | 74 | Colon Cancer | Adenocarcinoma | NA | SP assay followed by SFA and Western Blotting | 0.36 | 0.1739 | 25997915 |
| ABCG2 | 74 | Colon Cancer | NA | NA | IHC staining | 0.36 | 0.1739 | 31186779 |
| ABCG2 | 74 | Colon Cancer | NA | NA | IHC staining | 0.36 | 0.1739 | 31516883 |
| ABCG2 | 74 | Colon Cancer | NA | NA | qRT-PCR | 0.36 | 0.1739 | 24492635 |
| CTNNB1 | 2514 | Colon Cancer | NA | NA | IHC staining followed by Tumorigenicity assay | 0.36 | 0.0647 | 22902411 |
| CTNNB1 | 2514 | Colon Cancer | NA | NA | SFA followed by Western Blotting | 0.36 | 0.0647 | 33500430 |
| HMGA1 | 5010 | Colon Cancer | NA | NA | SFA and Western Blotting | 0.36 | 0.0042 | 24833610 |
| HMGA1 | 5010 | Colon Cancer | NA | NA | Western Blotting | 0.36 | 0.0042 | 24833610 |
| MSI1 | 7330 | Colon Cancer | NA | NA | SFA followed by Western Blotting | 0.36 | 0.0201 | 29110645 |
| ALDH1B1 | 407 | Colon Cancer | NA | NA | IHC staining | 0.32 | 0.0032 | 22670157 |
| ALDH1B1 | 407 | Colon Cancer | NA | NA | SFA followed by FACs | 0.32 | 0.0032 | 26383537 |
| CD24 | 1645 | Colon Cancer | NA | NA | IHC staining | 0.32 | 0.456 | 34609414 |
| CD24 | 1645 | Colon Cancer | NA | NA | IHC staining | 0.32 | 0.456 | 24696849 |
| CD24 | 1645 | Colon Cancer | NA | NA | FACs followed by SFA | 0.32 | 0.456 | 26745821 |
| CD24 | 1645 | Colon Cancer | NA | NA | FACs followed by SFA and Tumorigenicity assay | 0.32 | 0.456 | 30790680 |
| CD24 | 1645 | Colon Cancer | NA | NA | SFA followed by FACs | 0.32 | 0.456 | 18765800 |
| DCLK1 | 2700 | Colon Cancer | Adenocarcinoma | NA | IHC staining | 0.32 | 0.0159 | 28414327 |
| DPP4 | 3009 | Colon Cancer | NA | NA | IHC staining | 0.32 | 0.0085 | 34609414 |
| ITGB1 | 6153 | Colon Cancer | NA | NA | IHC staining | 0.32 | 0.018 | 22670157 |
| ABCB1 | 40 | Colon Cancer | NA | NA | SFA and qPCR | 0.28 | 0.0604 | 24944672 |
| BMI1 | 1066 | Colon Cancer | NA | NA | qRT-PCR | 0.28 | 0.1135 | 24492635 |
| BMI1 | 1066 | Colon Cancer | NA | NA | RT-PCR | 0.28 | 0.1135 | 31057717 |
| BMI1 | 1066 | Colon Cancer | NA | NA | SFA followed by qRT-PCR | 0.28 | 0.1135 | 23643941 |
| BMI1 | 1066 | Colon Cancer | NA | NA | SFA followed by FACs | 0.28 | 0.1135 | 27197180 |
| HES1 | 5192 | Colon Cancer | NA | NA | qRT-PCR and Tumorigenicity assay | 0.28 | 0.0095 | 24492635 |
| TWIST1 | 12428 | Colon Cancer | NA | NA | RT-PCR | 0.28 | 0.0191 | 23545848 |
| CXCR4 | 2561 | Colon Cancer | NA | NA | FACs | 0.2 | 0.0498 | 22871210 |
| ITGA6 | 6142 | Colon Cancer | NA | NA | FACs followed by CFA | 0.2 | 0.0265 | 18757407 |